• Madrigal Pharmaceuticals average return on tangible equity for 2024 was -88.89, a 67.22% decline from 2023.
• Madrigal Pharmaceuticals average return on tangible equity for 2023 was -271.19, a 36.52% decline from 2022.
• Madrigal Pharmaceuticals average return on tangible equity for 2022 was -198.64, a 120.88% increase from 2021.

Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.